Gain cutting-edge knowledge on the latest advances in cancer care to understand the impact on the endocrine system and long-term treatment options for survivors. The Oncoendocrinology SIG looks to increase interest in a niche area of practice and encourage collaboration in clinical care and research development.
Topics we will be reviewing include:
Developing academic oncoendocrinology clinical, educational and research programs;
Managing incident endocrine conditions in children and adults with cancer;
Diagnosing and treating endocrine-related adverse events from immune, hormonal and targeted cancer therapies;
Managing the long-term endocrine aspects of childhood and adult cancer survivors;
Understanding the mechanisms through which cancer and its treatments are linked to endocrine and metabolic conditions.
Collaborative webinar presented by Oncoendocrinology SIG and Transgender Research & Medicine SIG
Date: January 4, 2024 Time: 12:00 to 1:30 PM ET
Moderator: Ole-Petter R. Hamnvik, MB, BCh, BAO Case Presenters: Tugce Akcan, MD; and Ling Zhu, MB, BChir Expert Discussants: Ann Partridge, MD, MPH; Alexi Wright, MD, MPH; and Koen M. A. Dreijerink, MD, PhD
Description: As increasing numbers of transgender and gender diverse patients are seeking gender-affirming hormone treatment, more patients are needing to balance the risks and benefits of such treatment in the setting of known or newly diagnosed sex hormone-sensitive cancers (for example breast cancer and cancers of the reproductive tract). In this webinar, experts in oncology and gender-affirming care are discussing two clinical cases, providing their insights in the considerations that need to be made.
Learning Objectives:
Appraise current data on cancer risk with gender-affirming hormone therapy.
Summarize therapeutic approaches for gender affirmation in transgender patients who are diagnosed with sex-hormone sensitive cancers.
Contrast post-cancer diagnosis sex hormone management in cisgender people from management in transgender and gender diverse people.
The Metabolic Effects of Novel Cancer Therapies
April 24, 2023
Faculty:
Speakers:
Emily Gallagher
Associate Professor
Icahn Mount Sinai Hospital
Marcus DaSilva Goncalves, MD, PhD
Assistant Professor of Medicine
Weill Cornell Medicine in New York
Moderator:
Yee-Ming Melody Cheung, MBBS, PhD
Endocrinologist
Austin Health
Brigham and Women’s Hospital
Learning Objectives:
Describe novel small molecular inhibitors being used to treat a variety of cancers
Understand how these treatments can lead to systemic metabolic effects
Explain how dietary interventions may benefit individuals with cancer on targeted therapies
The Oncoendocrinology SIG held its inaugural webinar, Introduction to Oncoendocrinology, on September 27, 2022. Oncoendocrinology addresses the endocrine needs of cancer patients. Learn more about this emerging field and how it can be incorporated in your clinical practice.
Learning Objectives:
Describe the field of oncoendocrinology and the unique considerations relating to the clinical care of oncoendocrine patients
Review the infrastructure and model of care of an established oncoendocrine clinic.
Determine the obstacles and challenges associated with establishing an oncoendocrine clinic.
Gain cutting-edge knowledge on the latest advances in cancer care to understand the impact on the endocrine system and long-term treatment options for survivors. The Oncoendocrinology SIG looks to increase interest in a niche area of practice and encourage collaboration in clinical care and research development.